Clinical characteristics and antimicrobial susceptibilities of viridans streptococcal bacteremia during febrile neutropenia in patients with hematologic malignancies: a comparison between adults and children

[1] Castagnola E(2007)A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation Clin Infect Dis 45 1296-1304

[2] Fontana V(2011)Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america Clin Infect Dis 52 e56-93

[3] Caviglia I(2009)Etiology and clinical course of febrile neutropenia in children with cancer J Pediatr Hematol Oncol 31 623-629

[4] Caruso S(2011)Clinical investigation of bacteremia in children with hemato-oncologic diseases Infect Chemother 43 191-197

[5] Faraci M(2000)Serious complications of bacteremia caused by viridans streptococci in neutropenic patients with cancer Clin Infect Dis 31 1126-1130

[6] Fioredda F(1999)Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria Clin Infect Dis 29 490-494

[7] Garrè ML(2013)Epidemiology and clinical features of bloodstream infections in hematology wards: one year experience at the Catholic Blood and Marrow Transplantation Center Infect Chemother 45 51-61

[8] Moroni C(2004)Predictors of viridans streptococcal shock syndrome in bacteremic children with cancer and stem-cell transplant recipients J Clin Oncol 22 1222-1227

[9] Conte M(2005)Viridans streptococci bacteremia in children with malignancy: relevance of species identification and penicillin susceptibility Pediatr Infect Dis J 24 563-566

[10] Losurdo G(1997)Viridans streptococcal bacteraemia due to penicillin-resistant and penicillin-sensitive streptococci: analysis of risk factors and outcome in 60 patients from a single cancer centre before and after penicillin is used for prophylaxis Scand J Infect Dis 29 245-249

[1] Castagnola E(2007)A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation Clin Infect Dis 45 1296-1304

[2] Fontana V(2011)Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america Clin Infect Dis 52 e56-93

[3] Caviglia I(2009)Etiology and clinical course of febrile neutropenia in children with cancer J Pediatr Hematol Oncol 31 623-629

[4] Caruso S(2011)Clinical investigation of bacteremia in children with hemato-oncologic diseases Infect Chemother 43 191-197

[5] Faraci M(2000)Serious complications of bacteremia caused by viridans streptococci in neutropenic patients with cancer Clin Infect Dis 31 1126-1130

[6] Fioredda F(1999)Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria Clin Infect Dis 29 490-494

[7] Garrè ML(2013)Epidemiology and clinical features of bloodstream infections in hematology wards: one year experience at the Catholic Blood and Marrow Transplantation Center Infect Chemother 45 51-61

[8] Moroni C(2004)Predictors of viridans streptococcal shock syndrome in bacteremic children with cancer and stem-cell transplant recipients J Clin Oncol 22 1222-1227

[9] Conte M(2005)Viridans streptococci bacteremia in children with malignancy: relevance of species identification and penicillin susceptibility Pediatr Infect Dis J 24 563-566

[10] Losurdo G(1997)Viridans streptococcal bacteraemia due to penicillin-resistant and penicillin-sensitive streptococci: analysis of risk factors and outcome in 60 patients from a single cancer centre before and after penicillin is used for prophylaxis Scand J Infect Dis 29 245-249